SCHEMBL4673358

SCHEMBL4673358

Nc1ccc(-n2nnn(CCCc3ccccc3)c2=O)cc1

nearest known ligand 0.46

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
MAOB P27338 4/20 0.46
SIGMAR1 Q99720 3/20 0.46
ROCK2 O75116 1/20 0.44
MAOA P21397 2/20 0.41
GSK3A P49840 1/20 0.41
GSK3B P49841 1/20 0.41
TSHR P16473 1/20 0.39
DHODH Q02127 1/20 0.38
ALDH1A1 P00352 1/20 0.38
LMNA P02545 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
PFKFB3 Q16875 1/20 0.38
ADORA3 P0DMS8 1/20 0.38
ADORA2B P29275 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4672126 0.84 NPBWR1 (0.42) SIGMAR1ROCK2GSK3AGSK3BLMNA
SCHEMBL4670086 0.83 ROCK2 (0.61) ROCK2TSHRDHODH
SCHEMBL4673671 0.82 SIGMAR1 (0.52) SIGMAR1ALDH1A1L3MBTL1
SCHEMBL4673554 0.77 KMT2A (0.47) ROCK2TSHRDHODHALDH1A1ADORA3
SCHEMBL4670427 0.77 ADORA2B (0.41) ROCK2DHODHALDH1A1LMNAADORA3
SCHEMBL4670482 0.77 DHODH (0.36) MAOBROCK2MAOATSHRDHODH
Hydrochloric Acid SCHEMBL9384727 0.76 ADORA2B (0.40) ROCK2DHODHALDH1A1LMNAADORA3
SCHEMBL4670041 0.75 ADRB2 (0.42) DHODH
Water SCHEMBL4672111 0.74 ADRB2 (0.42) DHODHALDH1A1
SCHEMBL4670626 0.74 ADRB2 (0.40) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1054881-B1 NOVEL SULFONAMIDE SUBSTITUTED CHROMAN DERIVATIVES USEFUL AS BETA-3 ADRENORECEPTOR AGONISTS BAYER CORP (US) 2008-07-30 EP disclosed
US-6903218-B2 Sulfonamide substituted chroman derivatives BAYER PHARMACEUTICALS CORPORATION (US) 2005-06-07 US disclosed